Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy.

Literature DB >> 16891522

Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy.

Chee-Kin Hui¹, Scott Bowden, Hai-Ying Zhang, Anita Wong, Sharon Lewin, Frank Rousseau, Herve Mommeja-Marin, Nikki P Lee, John M Luk, Stephen Locarnini, Nancy Leung, Nikolai V Naoumov, George K K Lau.

Abstract

The performance characteristics of the RealART and Molecular Beacons assays were compared with those of the Digene Hybrid Capture II assay (ultrasensitive). The results of the RealART and Digene Hybrid assays were related (r = 0.94; P < 0.001) and diverged by 2 orders of magnitude. The RealART assay can be used to effectively monitor serum hepatitis B virus DNA levels.

Entities: Chemical Species

Mesh：

Substances：
DNA, Viral

Year: 2006 PMID： 16891522 PMCID： PMC1594658 DOI： 10.1128/JCM.02544-05

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

17 in total

1. Comparative evaluation of semiautomated COBAS AMPLICOR hepatitis B virus (HBV) monitor test and manual microwell plate-based AMPLICOR HBV MONITOR test.

Authors: I J Marin; M Poljak; K Seme; J Meglic-Volkar; M Maticic; G Lesnicar; V Brinovec
Journal: J Clin Microbiol Date: 2001-02 Impact factor: 5.948

2. Comparing methods of measurement: why plotting difference against standard method is misleading.

Authors: J M Bland; D G Altman
Journal: Lancet Date: 1995-10-21 Impact factor: 79.321

3. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B.

Authors: M Lindh; P Horal; A P Dhillon; G Norkrans
Journal: J Viral Hepat Date: 2000-07 Impact factor: 3.728

4. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system.

Authors: K R Loeb; K R Jerome; J Goddard; M Huang; A Cent; L Corey
Journal: Hepatology Date: 2000-09 Impact factor: 17.425

5. Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results.

Authors: Jérôme Dumortier; Philippe Chevallier; Jean-Yves Scoazec; Françoise Berger; Olivier Boillot
Journal: Am J Transplant Date: 2003-08 Impact factor: 8.086

6. Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay.

Authors: Joseph D C Yao; Marcel G H M Beld; Lynette Lin Ean Oon; Christopher H Sherlock; Jeffrey Germer; Sandra Menting; Su Yun Se Thoe; Linda Merrick; Rainer Ziermann; Johan Surtihadi; H James Hnatyszyn
Journal: J Clin Microbiol Date: 2004-02 Impact factor: 5.948

7. Multi-measurement method comparison of three commercial hepatitis B virus DNA quantification assays.

Authors: M Krajden; J Minor; L Cork; L Comanor
Journal: J Viral Hepat Date: 1998-11 Impact factor: 3.728

8. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

Authors: Patrick Marcellin; George K K Lau; Ferruccio Bonino; Patrizia Farci; Stephanos Hadziyannis; Rui Jin; Zhi-Meng Lu; Teerha Piratvisuth; Georgios Germanidis; Cihan Yurdaydin; Moises Diago; Selim Gurel; Ming-Yang Lai; Peter Button; Nigel Pluck
Journal: N Engl J Med Date: 2004-09-16 Impact factor: 91.245

9. Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays.

Authors: J M Pawlotsky; A Bastie; C Hézode; I Lonjon; F Darthuy; J Rémiré; D Dhumeaux
Journal: J Virol Methods Date: 2000-03 Impact factor: 2.014